NEW YORK – Some state laboratories have found that the novel coronavirus 2019-nCoV test kits sent by the US Centers for Disease Control and Prevention have provided inconclusive results during the quality control process, the CDC reported on Wednesday.
As a result, the CDC will likely need to remanufacture one of the kit reagents.